Dexcom (DXCM) EBT Margin (2010 - 2026)

Dexcom (DXCM) has 17 years of EBT Margin data on file, last reported at 22.61% in Q1 2026.

• On a quarterly basis, EBT Margin rose 772.0% year-over-year to 22.61% in Q1 2026; TTM through Mar 2026 was 24.98%, a 736.0% increase from a year earlier, with the FY2025 full-year figure at 23.35%, up 577.0% from the prior year.
• EBT Margin for Q1 2026 stood at 22.61%, down from 27.05% in the prior quarter.
• Over the last five years, EBT Margin for DXCM reached as high as 29.13% in Q3 2025 and fell as low as 5.74% in Q1 2022.
• Historically, EBT Margin has averaged 18.34% across 5 years, with a median of 18.7% in 2024.
• Across the five-year window, EBT Margin surged 1542 bps in 2022 and sank 681 bps in 2024, its largest moves.
• Year by year, EBT Margin stood at 16.34% in 2022, then soared by 46 bps to 23.8% in 2023, then decreased by 20 bps to 18.98% in 2024, then surged by 43 bps to 27.05% in 2025, then declined by 16 bps to 22.61% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 22.61% in Q1 2026, 27.05% in Q4 2025, and 29.13% in Q3 2025.